Posts

AI finds a way to people’s hearts (literally!)

Body  Credit: Daiju Ueda, OMU Body  Osaka, Japan – AI (artificial intelligence) ...

It worked in the Caribbean – What about here?

While there is extensive data on the high rates of HIV, STIs and unintended preg...

Biotechnology offers holistic approach to restoration o...

WEST LAFAYETTE, Ind. – Many at-risk forest tree species will probably need biote...

New Zealand kids spending one-third of after-school tim...

Regulations are urgently needed to protect children from harm in the unregulated...

Laser differential confocal Raman-Brillouin spectrum mi...

There are obvious differences between cancerous cells and normal cells in morpho...

AstraZeneca’s Phase III Lung Cancer Data Fails to Hit t...

AstraZeneca announced the main findings of a Phase III trial for an antibody-dru...

Celltrion Healthcare introduces a biosimilar version of...

Celltrion Healthcare, a biopharmaceutical company based in South Korea, has anno...

Does the hype around generative AI reflect its technolo...

ChatGPT's release to the public in November 2022 started a wave of global intere...

Incyte’s non-segmental vitiligo treatment approved in UK

Following FDA approival and CE marking for Incyte’s JAK-inhibiting cream Opzelur...

MHRA reveals new corporate plan to expedite drug regula...

The corporate strategy aims to introduce new legislation for faster regulations,...

EC approves Vertex’s Orkambi for cystic fibrosis in chi...

The EC approved extending the label for Vertex Pharmaceuticals’ Orkambi to treat...

FSD Pharma names Zeeshan Saeed as new CEO

FSD Pharma has named Zeeshan Saeed as the new chief executive officer (CEO) of t...

OSE Immunotherapeutics’ Tedopi gains US patent for canc...

The United States Patent and Trademark Office has provided a new patent for OSE ...

NHS to provide vision-saving drug to premature babies

The UK NHS has announced plans to provide ranibizumab for preventing blindness i...

RareStone’s narcolepsy therapy receives approval in China

The Chinese NMPA has granted approval for RareStone Group’s pitolisant to treat ...

Labcorp forms spin-off of Fortrea

The spin-off will create a new global Phase I-IV CRO, patient access and technol...